期刊文献+

妇女健康倡议(WHI)引发激素替代疗法新一轮争议 被引量:2

下载PDF
导出
摘要 长期以来激素替代疗法 (HRT) 的利与弊一直是极富争议和探讨意义的话题,自2002年7月美国妇女健康倡议 (WHI) 研究宣布提前终止部分HRT研究后,引发了世界范围内HRT医学专家们的关注和激烈讨论。时至今日,有关HRT的争论大致达成了某些共识,但仍存在一些争论,本文对此作简要综述。
作者 杨孝军
出处 《世界临床药物》 CAS 2003年第9期535-538,共4页 World Clinical Drug
  • 相关文献

参考文献16

  • 1National Toxicology Program (NTP):10th Report on Carcinogens.10th ed,2002.
  • 2Blake JM;Collins JA;Reid RL.The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women,2002(10).
  • 3Utian WH.What are the key issues women facewhen ending hormone replacement therapy[J],2003(02).
  • 4Rapp SR;Espeland MA;Shumaker SA.Effect of estrogen plus progestin on global cognitive function in postmenopausal women:the Women's Health initiative Memory Study:a randomized controlled trial[J],2003.
  • 5Shumaker SA;Legault C;Thai L.Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial[J],2003.
  • 6Ferrara A;Quesenberry CP;Karter A J.Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infamtion among women with diabetes: the Northern California Kaiser Permanent Diabetes Registry, 1995-1998,2003(01).
  • 7Solomon CG;Dluhy RG.Rethinking postmenopausal hormone therapy[J],2003(07).
  • 8Weiss LK;Burkman RT;Cushing-Haugen KL.Hormone replacement therapy regimens and breast cancer risk(1)[J],2002(06).
  • 9Anon.Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results form the Women's Health Initiative randomized controlled trial[J],2002.
  • 10Fletcher S W;Colditz G A.Failure of estrogen plus progestin therapy for prevention,2002.

二级参考文献29

共引文献56

同被引文献26

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部